|
"wagner anita k"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T14:51:00Z |
Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series study
|
Hsu, Jason C.;Lu, Christine Y.;Wagner, Anita K.;Chan, K. Arnold;Lai, Mei-Shu;Ross-Degnan, Dennis; Kin-Wei Chan; Hsu, Jason C.; Lu, Christine Y.; Lu, Christine Y.; Wagner, Anita K.; Chan, K. Arnold; Lai, Mei-Shu; Ross-Degnan, Dennis |
| 國立成功大學 |
2015/4/25 |
Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies
|
Hsu, Jason C; Dennis, Ross-Degnan; Wagner, Anita K; Cheng, Ching-Lan; Kao Yang, Yea-Huei; Zhang, Fang; Lu, Christine Y |
| 國立成功大學 |
2015-10 |
Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan
|
Hsu, Jason C.; Cheng, Ching-Lan; Ross-Degnan, Dennis; Wagner, Anita K.; Zhang, Fang; Yang, Yea-Huei Kao; Liu, Li-Ling; Tai, Hsueh-Yung; Chen, Ke-Hsin; Yang, Po-Wen; Lu, Christine Y. |
| 國立成功大學 |
2015-07 |
How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?
|
Hsu, Jason C.; Ross-Degnan, Dennis; Wagner, Anita K.; Zhang, Fang; Lu, Christine Y. |
| 國立成功大學 |
2014-10 |
Changes in Thiazolidinedione Utilization and Outcomes Following Safety Warning and Risk Evaluation & Mitigation Strategies (REMS) in Taiwan
|
Hsu, Jason C.; Ross-Degnan, Dennis; Cheng, Ching-Lan; Wagner, Anita K.; Zhang, Fang; Yang, Yea-Huei Kao; Liu, Li-Ling; Tai, Hsueh-Yung; Chen, Ke-Hsin; Yang, Po-Wen; Juan, Yi-Chen; Lu, Christine Y. |
| 國立臺灣大學 |
2014 |
Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series study
|
Hsu, Jason C.; Lu, Christine Y.; Wagner, Anita K.; Chan, K. Arnold; Lai, Mei-Shu; Ross-Degnan, Dennis; 陳建煒; 賴美淑 |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
